Fabior (Stiefel Laboratories, Inc.)
Welcome to the PulseAid listing for the Fabior drug offered from Stiefel Laboratories, Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Stiefel Laboratories, Inc. |
| NON-PROPRIETARY NAME: | tazarotene |
| SUBSTANCE NAME: | TAZAROTENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | AEROSOL, FOAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-09-04 |
| END MARKETING DATE: | 2018-09-30 |
Fabior HUMAN PRESCRIPTION DRUG Details:
| Item Description | Fabior from Stiefel Laboratories, Inc. |
| LABELER NAME: | Stiefel Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/g) |
| START MARKETING DATE: | 2013-09-04 |
| END MARKETING DATE: | 2018-09-30 |
| PRODUCT ID: | 0145-0020_b14ce1fc-f9f3-4410-b6ee-58d5cf1a12d7 |
| PRODUCT NDC: | 0145-0020 |
| APPLICATION NUMBER: | NDA202428 |
Other TAZAROTENE Pharmaceutical Manufacturers / Labelers:
